TSC2 and tuberous sclerosis: Since a decrease in melanocyte numbers and melanosome maturation hasbeen reported in ash-leaf macules of tuberous sclerosis patients harboringloss-of-function variants in TSC1 or TSC2, which encode upstream inhibitors of mTOR, westudied melanogenesis in patients with MTOR-related HI.